Antiviral drugs with the capacity to prevent virus attachment and entry by specifically targeting the S protein and cell surface protease could block the virus replication cycle and may be used as treatment approaches for COVID‐19 patients168, 169 (Figure 4). The gene discussed is PROS1; the disease is COVID-19.